Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3009390502;90503;90504 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
N2AB2845285579;85580;85581 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
N2A2752582798;82799;82800 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
N2B2102863307;63308;63309 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
Novex-12115363682;63683;63684 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
Novex-22122063883;63884;63885 chr2:178552623;178552622;178552621chr2:179417350;179417349;179417348
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Fn3-107
  • Domain position: 64
  • Structural Position: 97
  • Q(SASA): 0.1575
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F None None 1.0 D 0.873 0.715 0.857714189017 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8289 likely_pathogenic 0.76 pathogenic -1.963 Destabilizing 0.999 D 0.815 deleterious None None None None N
L/C 0.7353 likely_pathogenic 0.6526 pathogenic -1.705 Destabilizing 1.0 D 0.766 deleterious None None None None N
L/D 0.9938 likely_pathogenic 0.9896 pathogenic -1.116 Destabilizing 1.0 D 0.807 deleterious None None None None N
L/E 0.9563 likely_pathogenic 0.9224 pathogenic -1.068 Destabilizing 1.0 D 0.804 deleterious None None None None N
L/F 0.6545 likely_pathogenic 0.5753 pathogenic -1.456 Destabilizing 1.0 D 0.873 deleterious D 0.642688435 None None N
L/G 0.9454 likely_pathogenic 0.9142 pathogenic -2.322 Highly Destabilizing 1.0 D 0.797 deleterious None None None None N
L/H 0.9464 likely_pathogenic 0.908 pathogenic -1.479 Destabilizing 1.0 D 0.755 deleterious D 0.659515013 None None N
L/I 0.2873 likely_benign 0.2611 benign -1.024 Destabilizing 0.999 D 0.833 deleterious D 0.604300905 None None N
L/K 0.9617 likely_pathogenic 0.9389 pathogenic -1.275 Destabilizing 1.0 D 0.805 deleterious None None None None N
L/M 0.2627 likely_benign 0.2299 benign -1.014 Destabilizing 1.0 D 0.843 deleterious None None None None N
L/N 0.958 likely_pathogenic 0.9317 pathogenic -1.205 Destabilizing 1.0 D 0.812 deleterious None None None None N
L/P 0.9738 likely_pathogenic 0.9605 pathogenic -1.308 Destabilizing 1.0 D 0.801 deleterious D 0.659515013 None None N
L/Q 0.8551 likely_pathogenic 0.7595 pathogenic -1.338 Destabilizing 1.0 D 0.813 deleterious None None None None N
L/R 0.9392 likely_pathogenic 0.8977 pathogenic -0.764 Destabilizing 1.0 D 0.809 deleterious D 0.643495652 None None N
L/S 0.9489 likely_pathogenic 0.9154 pathogenic -1.987 Destabilizing 1.0 D 0.807 deleterious None None None None N
L/T 0.8455 likely_pathogenic 0.782 pathogenic -1.805 Destabilizing 1.0 D 0.834 deleterious None None None None N
L/V 0.2794 likely_benign 0.2481 benign -1.308 Destabilizing 0.999 D 0.841 deleterious D 0.595589371 None None N
L/W 0.9045 likely_pathogenic 0.8517 pathogenic -1.465 Destabilizing 1.0 D 0.727 prob.delet. None None None None N
L/Y 0.9207 likely_pathogenic 0.8811 pathogenic -1.233 Destabilizing 1.0 D 0.813 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.